Global Antibody-drug Conjugates Market Outlook 2022

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The global Antibody-drug Conjugates market was valued at US$ 2734.4 million in 2020 and is expected to reach US$ 3729.7 million by the end of 2027, growing at a CAGR of 4.7% during 2021-2027.

This report focuses on Antibody-drug Conjugates volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugates market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Antibody-drug Conjugates Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Adcetris

Kadcyla

Breast Cancer

Lymphoma

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

ImmunoGen

Seattle Genetics

Roche

Takeda

1.1 Product Overview and Scope of Antibody-drug Conjugates

1.2 Antibody-drug Conjugates Segment by Type

1.2.1 Global Antibody-drug Conjugates Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 Adcetris

1.2.3 Kadcyla

1.3 Antibody-drug Conjugates Segment by Application

1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application: (2021-2027)

1.3.2 Breast Cancer

1.3.3 Lymphoma

1.4 Global Antibody-drug Conjugates Market Size Estimates and Forecasts

1.4.1 Global Antibody-drug Conjugates Revenue 2016-2027

1.4.2 Global Antibody-drug Conjugates Sales 2016-2027

1.4.3 Antibody-drug Conjugates Market Size by Region: 2016 Versus 2021 Versus 2027

2.1 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2016-2021)

2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Antibody-drug Conjugates Manufacturing Sites, Area Served, Product Type

2.5 Antibody-drug Conjugates Market Competitive Situation and Trends

2.5.1 Antibody-drug Conjugates Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Antibody-drug Conjugates Players Market Share by Revenue

2.5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Antibody-drug Conjugates Retrospective Market Scenario in Sales by Region: 2016-2021

3.2 Global Antibody-drug Conjugates Retrospective Market Scenario in Revenue by Region: 2016-2021

3.3 North America Antibody-drug Conjugates Market Facts & Figures by Country

3.3.1 North America Antibody-drug Conjugates Sales by Country

3.3.2 North America Antibody-drug Conjugates Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Antibody-drug Conjugates Market Facts & Figures by Country

3.4.1 Europe Antibody-drug Conjugates Sales by Country

3.4.2 Europe Antibody-drug Conjugates Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Region

3.5.1 Asia Pacific Antibody-drug Conjugates Sales by Region

3.5.2 Asia Pacific Antibody-drug Conjugates Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Antibody-drug Conjugates Market Facts & Figures by Country

3.6.1 Latin America Antibody-drug Conjugates Sales by Country

3.6.2 Latin America Antibody-drug Conjugates Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Country

3.7.1 Middle East and Africa Antibody-drug Conjugates Sales by Country

3.7.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)

4.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021)

4.3 Global Antibody-drug Conjugates Price by Type (2016-2021)

5.1 Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)

5.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2021)

5.3 Global Antibody-drug Conjugates Price by Application (2016-2021)

6.1 ImmunoGen

6.1.1 ImmunoGen Corporation Information

6.1.2 ImmunoGen Description and Business Overview

6.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)

6.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio

6.1.5 ImmunoGen Recent Developments/Updates

6.2 Seattle Genetics

6.2.1 Seattle Genetics Corporation Information

6.2.2 Seattle Genetics Description and Business Overview

6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)

6.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio

6.2.5 Seattle Genetics Recent Developments/Updates

6.3 Roche

6.3.1 Roche Corporation Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)

6.3.4 Roche Antibody-drug Conjugates Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Takeda

6.4.1 Takeda Corporation Information

6.4.2 Takeda Description and Business Overview

6.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Takeda Antibody-drug Conjugates Product Portfolio

6.4.5 Takeda Recent Developments/Updates

7.1 Antibody-drug Conjugates Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Antibody-drug Conjugates

7.4 Antibody-drug Conjugates Industrial Chain Analysis

8.1 Marketing Channel

8.2 Antibody-drug Conjugates Distributors List

8.3 Antibody-drug Conjugates Customers

9.1 Antibody-drug Conjugates Industry Trends

9.2 Antibody-drug Conjugates Growth Drivers

9.3 Antibody-drug Conjugates Market Challenges

9.4 Antibody-drug Conjugates Market Restraints

10.1 Antibody-drug Conjugates Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Antibody-drug Conjugates by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Antibody-drug Conjugates by Type (2022-2027)

10.2 Antibody-drug Conjugates Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Antibody-drug Conjugates by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Antibody-drug Conjugates by Application (2022-2027)

10.3 Antibody-drug Conjugates Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Antibody-drug Conjugates by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Antibody-drug Conjugates by Region (2022-2027)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global Antibody-drug Conjugates Sales (Kg) Growth Rate Comparison by Type (2021-2027)

    Table 2. Global Antibody-drug Conjugates Sales (Kg) Comparison by Application (2021-2027)

    Table 3. Global Antibody-drug Conjugates Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)

    Table 4. Key Manufacturers Antibody-drug Conjugates Covered in This Study

    Table 5. Global Antibody-drug Conjugates Sales (Kg) of Key Manufacturers (2016-2021)

    Table 6. Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2016-2021)

    Table 7. Global Antibody-drug Conjugates Revenue (US$ Million) by Manufacturers (2016-2021)

    Table 8. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2016-2021)

    Table 9. Global Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Manufacturers (2016-2021)

    Table 10. Manufacturers Antibody-drug Conjugates Manufacturing Sites and Area Served

    Table 11. Manufacturers Antibody-drug Conjugates Product Type

    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2020)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)

    Table 16. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)

    Table 17. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)

    Table 18. North America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)

    Table 19. North America Antibody-drug Conjugates Sales Market Share by Country (2016-2021)

    Table 20. North America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)

    Table 21. North America Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)

    Table 22. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)

    Table 23. Europe Antibody-drug Conjugates Sales Market Share by Country (2016-2021)

    Table 24. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)

    Table 25. Europe Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)

    Table 26. Asia Pacific Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)

    Table 27. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region (2016-2021)

    Table 28. Asia Pacific Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)

    Table 29. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)

    Table 30. Latin America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)

    Table 31. Latin America Antibody-drug Conjugates Sales Market Share by Country (2016-2021)

    Table 32. Latin America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)

    Table 33. Latin America Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)

    Table 34. Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)

    Table 35. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2016-2021)

    Table 36. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)

    Table 37. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)

    Table 38. Global Antibody-drug Conjugates Sales (Kg) by Type (2016-2021)

    Table 39. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)

    Table 40. Global Antibody-drug Conjugates Revenue (Million US$) by Type (2016-2021)

    Table 41. Global Antibody-drug Conjugates Revenue Share by Type (2016-2021)

    Table 42. Global Antibody-drug Conjugates Price (USD/Kg) by Type (2016-2021)

    Table 43. Global Antibody-drug Conjugates Sales (Kg) by Application (2016-2021)

    Table 44. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)

    Table 45. Global Antibody-drug Conjugates Revenue (Million US$) by Application (2016-2021)

    Table 46. Global Antibody-drug Conjugates Revenue Share by Application (2016-2021)

    Table 47. Global Antibody-drug Conjugates Price (USD/Kg) by Application (2016-2021)

    Table 48. ImmunoGen Corporation Information

    Table 49. ImmunoGen Description and Business Overview

    Table 50. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 51. ImmunoGen Antibody-drug Conjugates Product

    Table 52. ImmunoGen Recent Developments/Updates

    Table 53. Seattle Genetics Corporation Information

    Table 54. Seattle Genetics Description and Business Overview

    Table 55. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 56. Seattle Genetics Antibody-drug Conjugates Product

    Table 57. Seattle Genetics Recent Developments/Updates

    Table 58. Roche Corporation Information

    Table 59. Roche Description and Business Overview

    Table 60. Roche Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 61. Roche Antibody-drug Conjugates Product

    Table 62. Roche Recent Developments/Updates

    Table 63. Takeda Corporation Information

    Table 64. Takeda Description and Business Overview

    Table 65. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

    Table 66. Takeda Antibody-drug Conjugates Product

    Table 67. Takeda Recent Developments/Updates

    Table 68. Production Base and Market Concentration Rate of Raw Material

    Table 69. Key Suppliers of Raw Materials

    Table 70. Antibody-drug Conjugates Distributors List

    Table 71. Antibody-drug Conjugates Customers List

    Table 72. Antibody-drug Conjugates Market Trends

    Table 73. Antibody-drug Conjugates Growth Drivers

    Table 74. Antibody-drug Conjugates Market Challenges

    Table 75. Antibody-drug Conjugates Market Restraints

    Table 76. Global Antibody-drug Conjugates Sales Forecast by Type (2022-2027) & (Kg)

    Table 77. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2022-2027)

    Table 78. Global Antibody-drug Conjugates Revenue Forecast by Type (2022-2027) & (US$ Million)

    Table 79. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2022-2027)

    Table 80. Global Antibody-drug Conjugates Sales Forecast by Application (2022-2027) & (Kg)

    Table 81. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2022-2027)

    Table 82. Global Antibody-drug Conjugates Revenue Forecast by Application (2022-2027) & (US$ Million)

    Table 83. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2022-2027)

    Table 84. Global Antibody-drug Conjugates Sales Forecast by Region (2022-2027) & (Kg)

    Table 85. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2022-2027)

    Table 86. Global Antibody-drug Conjugates Revenue Forecast by Region (2022-2027) & (US$ Million)

    Table 87. Global Antibody-drug Conjugates Revenue Market Share Forecast by Region (2022-2027)

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Antibody-drug Conjugates

    Figure 2. Global Antibody-drug Conjugates Market Share by Type in 2020 & 2027

    Figure 3. Adcetris Product Picture

    Figure 4. Kadcyla Product Picture

    Figure 5. Global Antibody-drug Conjugates Market Share by Application in 2020 & 2027

    Figure 6. Breast Cancer

    Figure 7. Lymphoma

    Figure 8. Global Antibody-drug Conjugates Revenue, (US$ Million), 2016 VS 2021 VS 2027

    Figure 9. Global Antibody-drug Conjugates Market Size 2016-2027 (US$ Million)

    Figure 10. Global Antibody-drug Conjugates Sales 2016-2027 (Kg)

    Figure 11. Global Antibody-drug Conjugates Market Size Market Share by Region: 2016 VS 20210 VS 2027

    Figure 12. Antibody-drug Conjugates Sales Share by Manufacturers in 2020

    Figure 13. Global Antibody-drug Conjugates Revenue Share by Manufacturers in 2020

    Figure 14. The Global 5 and 10 Largest Antibody-drug Conjugates Players: Market Share by Revenue in 2020

    Figure 15. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021

    Figure 16. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)

    Figure 17. Global Antibody-drug Conjugates Sales Market Share by Region in 2020

    Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)

    Figure 19. Global Antibody-drug Conjugates Revenue Market Share by Region in 2020

    Figure 20. U.S. Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 21. Canada Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 22. Germany Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 23. France Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 24. U.K. Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 25. Italy Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 26. Russia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 27. China Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 28. Japan Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 29. South Korea Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 30. India Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 31. Australia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 32. Taiwan Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 33. Indonesia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 34. Thailand Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 35. Malaysia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 36. Philippines Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 37. Vietnam Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 38. Mexico Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 39. Brazil Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 40. Argentina Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 41. Turkey Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 42. Saudi Arabia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 43. U.A.E Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 44. Sales Market Share of Antibody-drug Conjugates by Type (2016-2021)

    Figure 45. Sales Market Share of Antibody-drug Conjugates by Application (2016-2021)

    Figure 46. Sales Market Share of Antibody-drug Conjugates by Application in 2020

    Figure 47. Revenue Share of Antibody-drug Conjugates by Application (2016-2021)

    Figure 48. Revenue Share of Antibody-drug Conjugates by Application in 2020

    Figure 49. Manufacturing Cost Structure of Antibody-drug Conjugates

    Figure 50. Manufacturing Process Analysis of Antibody-drug Conjugates

    Figure 51. Antibody-drug Conjugates Industrial Chain Analysis

    Figure 52. Channels of Distribution

    Figure 53. Distributors Profiles

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed